Reports of reduced KCNK17 mRNA levels in atrial fibrillation [10] and heart failure [22,40] suggest a role for K2P17.1 (TALK-2) in the pathophysiology of important cardiac pathologies. This evidence concerns the gene KCNK17 and atrial fibrillation.